Ameritas Investment Partners, Inc. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$217,252
+41.2%
7,974
+15.3%
0.01%
+50.0%
Q2 2023$153,814
+2.7%
6,9130.0%0.01%0.0%
Q1 2023$149,736
-10.4%
6,9130.0%0.01%
-14.3%
Q4 2022$167,087
+2.5%
6,913
+8.1%
0.01%0.0%
Q3 2022$163,000
+7.2%
6,3950.0%0.01%0.0%
Q2 2022$152,000
-0.7%
6,395
-5.7%
0.01%
+16.7%
Q1 2022$153,000
+2.0%
6,780
-10.6%
0.01%
+20.0%
Q4 2021$150,000
+0.7%
7,5810.0%0.01%0.0%
Q3 2021$149,000
-10.8%
7,5810.0%0.01%
-16.7%
Q2 2021$167,000
-13.9%
7,581
-6.9%
0.01%
-14.3%
Q1 2021$194,000
-8.9%
8,1440.0%0.01%
-30.0%
Q4 2020$213,000
+50.0%
8,1440.0%0.01%
+66.7%
Q3 2020$142,000
+3.6%
8,1440.0%0.01%
-14.3%
Q2 2020$137,000
+41.2%
8,1440.0%0.01%
+16.7%
Q1 2020$97,000
-2.0%
8,1440.0%0.01%
+50.0%
Q4 2019$99,000
-13.9%
8,1440.0%0.00%
-20.0%
Q3 2019$115,000
+26.4%
8,1440.0%0.01%
+25.0%
Q2 2019$91,000
-5.2%
8,1440.0%0.00%0.0%
Q1 2019$96,000
-11.9%
8,1440.0%0.00%
-33.3%
Q4 2018$109,000
-4.4%
8,1440.0%0.01%
+20.0%
Q3 2018$114,000
-10.9%
8,1440.0%0.01%
-16.7%
Q2 2018$128,000
-3.0%
8,144
+1.8%
0.01%0.0%
Q1 2018$132,000
-8.3%
8,0010.0%0.01%
-14.3%
Q4 2017$144,000
+8.3%
8,0010.0%0.01%
+16.7%
Q3 2017$133,000
+41.5%
8,0010.0%0.01%
+20.0%
Q2 2017$94,000
+46.9%
8,001
+37.5%
0.01%
+66.7%
Q1 2017$64,0005,8200.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders